Imprinted genes in placental growth and obstetric disorders (original) (raw)
Article navigation
Review Articles| March 30 2006
Institute for Cancer Genetics and Department of Pathology, Columbia University, New York, NY (USA)
Search for other works by this author on:
Cytogenet Genome Res (2006) 113 (1-4): 271–278.
Abstract
Genomic imprinting has a special role in placental biology. Imprinted genes are often strongly expressed in the placenta, and the allelic expression bias due to imprinting is sometimes stronger in this extraembryonic organ than in the embryo and adult. Mutations, epimutations, and uniparental disomies affecting imprinted loci cause placental stunting or overgrowth in mice and humans, and placental neoplasms (complete hydatidiform moles) are androgenetic. Whether imprinted genes might also play a role in the more common medical conditions that affect the placenta, including preeclampsia and intrauterine growth restriction (IUGR), is an important question that is now receiving some attention. Here we review this area and describe recent data indicating altered expression of imprinted genes in the placental response to maternal vascular underperfusion associated with IUGR.
References
Alders M, Hodges M, Hadjantonakis AK, Postmus J, van Wijk I, Bliek J, de Meulemeester M, Westerveld A, et al: The human Achaete-Scute homologue 2 (ASCL2, HASH2) maps to chromosome 11p15.5 close to IGF2 and is expressed in extravillus trophoblasts. Hum Mol Genet 6:859–867 (1997).
Baker J, Liu JP, Robertson EJ, Efstratiadis A: Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73–82 (1993).
Caspary T, Cleary MA, Baker CC, Guan XJ, Tilghman SM: Multiple mechanisms regulate imprinting of the mouse distal chromosome 7 gene cluster. Mol Cell Biol 18:3466–3474 (1998).
Caspary T, Cleary MA, Perlman EJ, Zhang P, Elledge SJ, Tilghman SM: Oppositely imprinted genes p57(Kip2) and Igf2 interact in a mouse model for Beckwith-Wiedemann syndrome. Genes Dev 13:3115–3124 (1999).
Castrillon DH, Sun D, Weremowicz S, Fisher RA, Crum CP, Genest DR: Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2. Am J Surg Pathol 25:1225–1230 (2001).
Charalambous M, Smith FM, Bennett WR, Crew TE, Mackenzie F, Ward A: Disruption of the imprinted Grb10 gene leads to disproportionate overgrowth by an Igf2-independent mechanism. Proc Natl Acad Sci USA 100:8292–8297 (2003).
Chilosi M, Piazzola E, Lestani M, Benedetti A, Guasparri I, Granchelli G, Aldovini D, Leonardi E, Pizzolo G, Doglioni C, et al: Differential expression of p57kip2 a maternally imprinted cdk inhibitor in normal human placenta and gestational trophoblastic disease. Lab Invest 78:269–276 (1998).
Constancia M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, Stewart F, Kelsey G, Fowden A, Sibley C, Reik W: Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 417:945–948 (2002).
Cozier GE, Carlton J, Bouyoucef D, Cullen PJ: Membrane targeting by pleckstrin homology domains. Curr Top Microbiol Immunol 282:49–88 (2004).
Curley JP, Pinnock SB, Dickson SL, Thresher R, Miyoshi N, Surani MA, Keverne EB: Increased body fat in mice with a targeted mutation of the paternally expressed imprinted gene Peg3. FASEB J 19:1302–1304 (2005).
Dao D, Frank D, Qian N, O’Keefe D, Vosatka RJ, Walsh CP, Tycko B: IMPT1 an imprinted gene similar to polyspecific transporter and multi-drug resistance genes. Hum Mol Genet 7:597–608 (1998).
Dao D, Walsh CP, Yuan L, Gorelov D, Feng L, Hensle T, Nisen P, Yamashiro DJ, Bestor TH, Tycko B: Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region gene specificity of H19 silencing in Wilms’ tumorigenesis and methylation hyper-dependence of H19 imprinting. Hum Mol Genet 8:1337–1352 (1999).
Eggenschwiler J, Ludwig T, Fisher P, Leighton PA, Tilghman SM, Efstratiadis A: Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes Dev 11:3128–3142 (1997).
El-Maarri O, Seoud M, Coullin P, Herbiniaux U, Oldenburg J, Rouleau G, Slim R: Maternal alleles acquiring paternal methylation patterns in biparental complete hydatidiform moles. Hum Mol Genet 12:1405–1413 (2003).
Fisher RA, Hodges MD, Rees HC, Sebire NJ, Seckl MJ, Newlands ES, Genest DR, Castrillon DH: The maternally transcribed gene p57(KIP2) (CDNK1C) is abnormally expressed in both androgenetic and biparental complete hydatidiform moles. Hum Mol Genet 11:3267–3272 (2002).
Fisher RA, Hodges MD, Newlands ES: Familial recurrent hydatidiform mole: a review. J Reprod Med 49:595–601 (2004a).
Fisher RA, Nucci MR, Thaker HM, Weremowicz S, Genest DR, Castrillon DH: Complete hydatidiform mole retaining a chromosome 11 of maternal origin: molecular genetic analysis of a case. Mod Pathol 17:1155–1160 (2004b).
Fitzpatrick GV, Soloway PD, Higgins MJ: Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1. Nat Genet 32:426–431 (2002).
Frank D, Mendelsohn CL, Ciccone E, Svensson K, Ohlsson R, Tycko B: A novel pleckstrin homology-related gene family defined by Ipl/Tssc3, TDAG51 and Tih1: tissue-specific expression, chromosomal location and parental imprinting. Mamm Genome 10:1150–1159 (1999).
Frank D, Fortino W, Clark L, Musalo R, Wang W, Saxena A, Li CM, Reik W, Ludwig T, Tycko B: Placental overgrowth in mice lacking the imprinted gene Ipl. Proc Natl Acad Sci USA 99:7490–7495 (2002).
Gluckman PD: Endocrine and nutritional regulation of prenatal growth. Acta Paediatr Suppl 423:153–158 (1997).
Guillemot F, Caspary T, Tilghman SM, Copeland NG, Gilbert DJ, Jenkins NA, Anderson DJ, Joyner AL, Rossant J, Nagy A: Genomic imprinting of Mash2, a mouse gene required for trophoblast development. Nat Genet 9:235–242 (1995).
Haig D: Altercation of generations: genetic conflicts of pregnancy. Am J Reprod Immunol 35:226–232 (1996).
Haig D, Graham C: Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell 64:1045–1046 (1991).
Han VK, Carter AM: Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. Placenta 21:289–305 (2000).
He H, Olesnanik K, Nagy R, Liyanarachchi S, Prasad ML, Stratakis CA, Kloos RT, Chapelle Ade L: Allelic variation in gene expression in thyroid tissue. Thyroid 15:660–667 (2005).
Helwani MN, Seoud M, Zahed L, Zaatari G, Khalil A, Slim R: A familial case of recurrent hydatidiform molar pregnancies with biparental genomic contribution. Hum Genet 105:112–115 (1999).
Hiby SE, Lough M, Keverne EB, Surani MA, Loke YW, King A: Paternal monoallelic expression of PEG3 in the human placenta. Hum Mol Genet 10:1093–1100 (2001).
Itoh T, Takenawa T: Phosphoinositide-binding domains: Functional units for temporal and spatial regulation of intracellular signalling. Cell Signal 14:733–743 (2002).
Kanayama N, Takahashi K, Matsuura T, Sugimura M, Kobayashi T, Moniwa N, Tomita M, Nakayama K: Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice. Mol Hum Reprod 8:1129–1135 (2002).
Kaneko-Ishino T, Kuroiwa Y, Miyoshi N, Kohda T, Suzuki R, Yokoyama M, Viville S, Barton SC, Ishino F, Surani MA: Peg1/Mest imprinted gene on chromosome 6 identified by cDNA subtraction hybridization. Nat Genet 11:52–59 (1995).
Kim J, Ashworth L, Branscomb E, Stubbs L: The human homolog of a mouse-imprinted gene Peg3 maps to a zinc finger gene-rich region of human chromosome 19q13.4. Genome Res 7:532–540 (1997).
Kobayashi S, Kohda T, Miyoshi N, Kuroiwa Y, Aisaka K, Tsutsumi O, Kaneko-Ishino T, Ishino F: Human PEG1/MEST an imprinted gene on chromosome 7. Hum Mol Genet 6:781–786 (1997).
Lee MH, Reynisdottir I, Massague J: Cloning of p57KIP2 a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9:639–649 (1995).
Lefebvre L, Viville S, Barton SC, Ishino F, Surani MA: Genomic structure and parent-of-origin-specific methylation of Peg1. Hum Mol Genet 6:1907–1915 (1997).
Lemmon MA, Ferguson KM, Abrams CS: Pleckstrin homology domains and the cytoskeleton. FEBS Lett 513:71–76 (2002).
Lewis A, Mitsuya K, Umlauf D, Smith P, Dean W, Walter J, Higgins M, Feil R, Reik W: Imprinting on distal chromosome 7 in the placenta involves repressive histone methylation independent of DNA methylation. Nat Genet 36:1291–1295 (2004).
Li CM, Margolin A, Salas M, Memeo L, Mansukhani M, Hibshoosh H, Szaboics M, Klinakis A,Tycko B: PEG10 is a cMYC target gene in cancer cells. Cancer Res 66:665–672 (2006).
Ludwig T, Eggenschwiler J, Fisher P, D’Ercole AJ, Davenport ML, Efstratiadis A: Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol 177:517–535 (1996).
Lustig O, Ariel I, Ilan J, Lev-Lehman E, De-Groot N, Hochberg A: Expression of the imprinted gene H19 in the human fetus. Mol Reprod Dev 38:239–246 (1994).
Mayer W, Hemberger M, Frank HG, Grummer R, Winterhager E, Kaufmann P, Fundele R: Expression of the imprinted genes MEST/Mest in human and murine placenta suggests a role in angiogenesis. Dev Dyn 217:1–10 (2000).
McMinn J, Wei M, Schupf N, Cusmai J, Johnson EB, Smith AC, Weksberg R, Thaker H, Tycko B: Unbalanced expression of imprinted genes in human intrauterine growth restriction. Placenta in press (2005).
McMinn J, Wei M, Sadovsky Y, Thaker H, Tycko B: Imprinting of PEG1/MEST isoform-2 in human placenta. Placenta 27:119–126 (2006).
Mutter GL, Stewart CL, Chaponot ML, Pomponio RJ: Oppositely imprinted genes H19 and insulin-like growth factor 2 are coexpressed in human androgenetic trophoblast. Am J Hum Genet 53:1096–1102 (1993).
Nakayama H, Liu Y, Stifani S, Cross JC: Developmental restriction of Mash-2 expression in trophoblast correlates with potential activation of the notch-2 pathway. Dev Genet 21:21–30 (1997).
Nishita Y, Yoshida I, Sado T, Takagi N: Genomic imprinting and chromosomal localization of the human MEST gene. Genomics 36:539–542 (1996).
Okabe H, Satoh S, Furukawa Y, Kato T, Hasegawa S, Nakajima Y, Yamaoka Y, Nakamura Y: Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. Cancer Res 63:3043–3048 (2003).
Okita C, Meguro M, Hoshiya H, Haruta M, Sakamoto YK, Oshimura M: A new imprinted cluster on the human chromosome 7q21→q31 identified by human-mouse monochromosomal hybrids. Genomics 81:556–559 (2003).
Ono R, Shiura H, Aburatani H, Kohda T, Kaneko-Ishino T, Ishino F: Identification of a large novel imprinted gene cluster on mouse proximal chromosome 6. Genome Res 13:1696–1705 (2003).
Oudejans CB, Mulders J, Lachmeijer AM, van Dijk M, Konst AA, Westerman BA, van Wijk IJ, Leegwater PA, et al: The parent-of-origin effect of 10q22 in pre-eclamptic females coincides with two regions clustered for genes with down-regulated expression in androgenetic placentas. Mol Hum Reprod 10:589–598 (2004).
Panichkul PC, Al-Hussaini TK, Sierra R, Kashork CD, Popek EJ, Stockton DW, Van den Veyver IB: Recurrent biparental hydatidiform mole: additional evidence for an 11-Mb locus in 19q13.4 and candidate gene analysis. J Soc Gynecol Investig 12:376–383 (2005).
Qian N, Frank D, O’Keefe D, Dao D, Zhao L, Yuan L, Wang Q, Keating M, Walsh C, Tycko B: The IPL gene on chromosome 11p15.5 is imprinted in humans and mice and is similar to TDAG51 implicated in Fas expression and apoptosis. Hum Mol Genet 6:2021–2029 (1997).
Redline RW, Chernicky CL, Tan HQ, Ilan J, Ilan J: Differential expression of insulin-like growth factor-II in specific regions of the late (post day 95) murine placenta. Mol Reprod Dev 36:121–129 (1993).
Riesewijk AM, Hu L, Schulz U, Tariverdian G, Hoglund P, Kere J, Ropers HH, Kalscheuer VM: Monoallelic expression of human PEG1/MEST is paralleled by parent-specific methylation in fetuses. Genomics 42:236–244 (1997).
Roberts DJ, Mutter GL: Advances in the molecular biology of gestational trophoblastic disease. J Reprod Med 39:201–208 (1994).
Salas M, John R, Saxena A, Barton S, Frank D, Fitzpatrick G, Higgins MJ, Tycko B: Placental growth retardation due to loss of imprinting of Phlda2. Mech Dev 121:1199–1210 (2004).
Saxena A, Morozov P, Frank D, Musalo R, Lemmon MA, Skolnik EY, Tycko B: Phosphoinositide binding by the pleckstrin homology domains of Ipl and Tih1. J Biol Chem 277:49935–49944 (2002).
Saxena A, Frank D, Panichkul P, Van den Veyver IB, Tycko B, Thaker H: The product of the imprinted gene IPL marks human villous cytotrophoblast and is lost in complete hydatidiform mole. Placenta 24:835–842 (2003).
Sensi A, Gualandi F, Pittalis MC, Calabrese O, Falciano F, Maestri I, Bovicelli L, Calzolari E: Mole maker phenotype: possible narrowing of the candidate region. Eur J Hum Genet 8:641–644 (2000).
Shiura H, Miyoshi N, Konishi A, Wakisaka-Saito N, Suzuki R, Muguruma K, Kohda T, Wakana S, Yokoyama M, Ishino F, Kaneko-Ishino T: Meg1/Grb10 overexpression causes postnatal growth retardation and insulin resistance via negative modulation of the IGF1R and IR cascades. Biochem Biophys Res Commun 329:909–916 (2005).
Sunde L, Vejerslev LO, Jensen MP, Pedersen S, Hertz JM, Bolund L: Genetic analysis of repeated biparental diploid hydatidiform moles. Cancer Genet Cytogenet 66:16–22 (1993).
Takahashi K, Kobayashi T, Kanayama N: p57(Kip2) regulates the proper development of labyrinthine and spongiotrophoblasts. Mol Hum Reprod 6:1019–1025 (2000).
Takahashi M, Kamei Y, Ezaki O: Mest/Peg1 imprinted gene enlarges adipocytes and is a marker of adipocyte size. Am J Physiol Endocrinol Metab 288:E117–124 (2005).
Tanaka M, Gertsenstein M, Rossant J, Nagy A: Mash2 acts cell autonomously in mouse spongiotrophoblast development. Dev Biol 190:55–65 (1997).
Thaker HM, Berlin A, Tycko B, Goldstein DP, Berkowitz RS, Castrillon DH, Genest DR: Immunohistochemistry for the imprinted gene product IPL/PHLDA2 for facilitating the differential diagnosis of complete hydatidiform mole. J Reprod Med 49:630–636 (2004).
Tsou AP, Chuang YC, Su JY, Yang CW, Liao YL, Liu WK, Chiu JH, Chou CK: Overexpression of a novel imprinted gene PEG10 in human hepatocellular carcinoma and in regenerating mouse livers. J Biomed Sci 10:625–635 (2003).
Tycko B, Mannens M: Beckwith-Wiedemann syndrome, in Jorde L (ed): Encyclopedia of Genetics, Genomics and Proteomics (John Wiley & Sons, West Sussex 2005).
Umlauf D, Goto Y, Cao R, Cerqueira F, Wagschal A, Zhang Y, Feil R: Imprinting along the Kcnq1 domain on mouse chromosome 7 involves repressive histone methylation and recruitment of Polycomb group complexes. Nat Genet 36:1296–1300 (2004).
van Dijk M, Mulders J, Konst A, Janssens B, van Roy F, Blankenstein M, Oudejans C: Differential downregulation of alphaT-catenin expression in placenta: trophoblast cell type-dependent imprinting of the CTNNA3 gene. Gene Expr Patterns 5:61–65 (2004).
van Dijk M, Mulders J, Poutsma A, Konst AA, Lachmeijer AM, Dekker GA, Blankenstein MA, Oudejans CB: Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family. Nat Genet 37:514–519 (2005).
Wutz A, Theussl HC, Dausman J, Jaenisch R, Barlow DP, Wagner EF: Non-imprinted Igf2r expression decreases growth and rescues the Tme mutation in mice. Development 128:1881–1887 (2001).
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
Sign in
Digital Version
Pay-Per-View Access
$39.00
1 Karger Article Bundle Token
$150
Rental
This article is also available for rental through DeepDyve. 